LATEST ALERTS
US-based 22nd Century will sell its hemp/cannabis subsidiary, GVB Biopharma, to an entity affiliated with current GVB employees and will use the sale proceeds to pay off debt and further deleverage its balance sheet
US hemp farmers will be able to continue operating under the 2018 Farm Bill framework until the end of September next year, as stopgap funding was approved and signed into law by president Joe Biden
A British American Tobacco (BAT) subsidiary is investing a further CAD124.6m (USD90.2m) in its strategic partnership with Canadian licensed cannabis producer Organigram
22nd Century reported decreased revenues for the third quarter of 2023 and blamed demand challenges in its hemp/cannabis product distribution business, although this still represents the biggest part of its net revenue
Partisan gridlock continues to keep Congress from clarifying the regulatory framework for CBD. Even as the Biden administration moves to reschedule cannabis, Congress punts CBD issues back and forth with the FDA
Stakeholders are feeling more optimistic that relief could be on its way for the US cannabis industry, which is currently struggling
US cannabis rescheduling could eventually lead to companies saving around $2bn a year in federal taxes, a recent cannabis economics report claims, by allowing businesses to deduct their business expenses on their federal tax returns
Another major Canadian cannabinoid company is leaving the US market amid concerns over the regulatory environment some say the US Food and Drug Administration has caused
The US Department of Health and Human Services recommendation to reschedule cannabis to a less restrictive schedule could be the boon that the besieged cannabis industry needs
Young US adults are more likely to use cannabis than to vape or smoke cigarettes, says a new Gallup poll, and concerns about cannabis use are not comparable to fears around vaping and smoking
22nd Century announced a positive second-quarter result for its cannabinoid business, with the division supplying most of its quarterly revenue
Attempts to legalise adult recreational cannabis use continue to stall across Latin America, with Colombia the latest example there of a nation where what looked a promising bid has fallen short
The Argentine government has finally put enough flesh on the bones of its laws to allow the development of a hemp industry and expansion of its medical cannabis sector
Major cannabis firms are streamlining their North American operations and reallocating resources toward markets with what they see as more long-term growth potential
Women started entering the cannabis sector right at its beginning, and by 2015 over one third of US executives in cannabis companies were female. In 2017 this figure was down to 26%
When it comes to rules for businesses like cannabis consumption lounges, Canadian entrepreneurs face a complicated patchwork quilt of provincial and municipal laws
The US Federal Trade Commission and Food and Drug Administration have sent warning letters to six sellers of delta-8 THC edibles whose packaging is very similar to that of popular snacks and sweets for children
Making coverage of medical cannabis mandatory for insurers is one of the biggest potential spurs for growth in the sector. And companies operating in South America hope Colombia could follow the German path
Canopy Growth will stop producing its own cannabis beverages, edibles, vapes and extracts as it continues to look at ways to increase profitability. Using a third-party sourcing model for these products will allow it to free up funds
In another setback to Latin America’s cannabis industry, a bill to legalise the sale of adult use cannabis in Colombia fell just short of the votes required in a final Senate debate
A historic law that seeks to legalise the sale and distribution of recreational cannabis in Colombia is in jeopardy of being shelved after the country’s Senate failed to vote on the initiative on 15th June
Canada’s Competition Bureau says federal government policies are making it more difficult for the country’s fledgling legal cannabis industry to compete with the illegal market
Legal recreational cannabis sales for adult use are expected to begin next year in Minnesota following agreement on a bill between the state’s House and Senate
Hemp production in the US suffered a major decline last year, with the planted area shrinking by 48% against 2021 and the total value of the harvested crop falling by 71%
US-based 22nd Century reported record cannabinoid ingredient volumes delivered in the first quarter of 2023 and expects those to increase further throughout the year
Twitter has claimed to have made another “major” step forward in cannabis advertising. But again the devil is in the details, which remain vague and contradictory
Mexican president Andrés Manuel López Obrador alleged that cannabis permits awarded to companies linked to former president Vicente Fox in 2018 involved influence peddling and corruption
California-based e-cigarette manufacturer Ispire Technology has signed a partnership with US cannabis brand Cookies to sell CBD vapes across the United States
While politicians leave the question unanswered, the growing and importing of low-THC cannabis for medical and industrial uses could become legal in Brazil through a decision by the country’s most senior judges
Producer Rubicon Organics delivered net revenue of CAD35.5m (USD26.1m) for the year ending 31st December 2022, which represents significant net revenue growth of 57% compared to 2021
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
